Donate money to KEI
Listserves
Main Areas of Work
Videos
Events
Publications
Blogs
About KEI
Search this site:
Knowledge Ecology International
Attending and mending the knowledge ecosystem
Navigation
Site Map
Recent posts
Feed aggregator
Polls
Groups
Round II of the
Paris Accord
took place in Paris on October 23 and 24, 2009.
Book navigation
Copyright and Related Rights
About KEI
Access to Medical Technologies
Competition Policy
Databases
Economics of Creativity and Knowledge
Enforcement and Remedies to Infringement
Events
General Access to Knowledge Issues
Government Funded Inventions
Knowledge Governance Fora
The Anti-Counterfeiting Trade Agreement (ACTA)
World Intellectual Property Organization (WIPO)
European Union
Non Communicable Disease (NCD) negotiations
PAIPO
Trans-Pacific Partnership Agreement (TPPA)
UNESCO
United States Trade Representative (USTR)
World Health Organization (WHO)
CEWG: WHO Consultative Expert Group on R&D Financing
Expert Working Group on R&D Financing
1998/1999 debate over 52.19, the WHO Revised Drug Strategy
KEI March 2, 2007 letter to WHO on the Model Essential Medicines List
The World Health Assembly takes step back, but leaves door open, for medical R&D Treaty
Views on the 60th World Health Assembly IGWG resolution
Views on the 61st World Health Assembly adoption of Global Strategy on Public Health, Innovation and Intellectual Property
WHO issues mild statement on transit of medicines
Why does Bill Gates oppose discussions of a medical R&D treaty at the World Health Organization?
WikiLeaks cable details UK/US strategy during IGWG negotiations in 2007
World Trade Organization (WTO)
Medical diseases, conditions and technologies
Nuclear Proliferation
Patent Policy
Prizes to stimulate innovation
Publications and Research Notes
Timelines
Transparency
User login
Log in using OpenID:
What is OpenID?
Username:
*
Password:
*
Log in using OpenID
Cancel OpenID login
Request new password
Home
»
Knowledge Governance Fora
World Health Organization (WHO)
View
What links here
WHO
CEWG: WHO Consultative Expert Group on R&D Financing
Expert Working Group on R&D Financing
1998/1999 debate over 52.19, the WHO Revised Drug Strategy
KEI March 2, 2007 letter to WHO on the Model Essential Medicines List
The World Health Assembly takes step back, but leaves door open, for medical R&D Treaty
Views on the 60th World Health Assembly IGWG resolution
Views on the 61st World Health Assembly adoption of Global Strategy on Public Health, Innovation and Intellectual Property
WHO issues mild statement on transit of medicines
Why does Bill Gates oppose discussions of a medical R&D treaty at the World Health Organization?
WikiLeaks cable details UK/US strategy during IGWG negotiations in 2007
‹ USTR's 2012 Special 301 Report, focuses on largest developing country markets, and Canada
up
CEWG: WHO Consultative Expert Group on R&D Financing ›
Printer-friendly version
Send by email
